Endra Life Sciences Inc (NDRA)

[apollo1452]

The opinion on NDRA that counts is that of GE Healthcare & they want to lock up the rights to TAEUS.

TAEUS just received CE Mark approval for sales in Europe, we will get a commercialization update on the 3/26 scheduled CC.

GE Healthcare did extensive research on NDRA, renewed their Collaborative Research Agreement & is negotiating with NDRA for a TAEUS Exclusive Ultrasound Manufacturing Relationship.

Those facts demonstrate significant confidence in the technology that NDRA has developed & GE will assist NDRA with TAEUS marketing & sales.

The ALT blood test that checks for liver damage is unreliable with NAFLD & NASH, the medical community is desperate for TAEUS.

NDRA is not just targeting hospitals & medical centers for TAEUS sales but also NASH/NAFLD pharma companies & research labs.

Also consider the positive opinions of 800+ radiologists, pathologists, gastroenterologists & endocrinologists who have volunteered to collaborate with the TAEUS rollout.